Glimelius B, Enblad G, Kalkner M, Gustavsson A, Jakobsson M, Branehog I, Lenner P, Bjorkholm M
Department of Oncology, Akademiska Hospital, Uppsala, Sweden.
Leuk Lymphoma. 1996 Mar;21(1-2):71-8. doi: 10.3109/10428199609067582.
Since 1985 a Swedish National Care Programme has provided tailored principles for the diagnosis, staging, treatment and follow-up of patients with Hodgkin's disease (HD). This report gives the rationale behind the recommendations and presents treatment results for 648 patients diagnosed between 1985 and 1989 after a median follow-up of 70 months. Two hundred and twenty-nine (35%) patients were over 60 years of age. Treatment results for patients below 60 years of age in early and intermediate stages were favourable, provided the recommendations were followed. In advanced stages, the outcome was inferior in patients with CS IIB bulky disease and stage IVB. The prognosis of elderly patients remains poor, although it is too early to evaluate any impact of revisions made in 1989. The tailored principles, which usually entail less staging and/or treatment than is generally the case in the early and intermediate stages, produced favourable results when applied to an unselected group of patients with HD. Only minor changes were made in the recommendations during the 1994 revision.
自1985年以来,瑞典国家护理计划为霍奇金病(HD)患者的诊断、分期、治疗和随访提供了量身定制的原则。本报告阐述了这些建议背后的基本原理,并呈现了1985年至1989年间确诊的648例患者的治疗结果,这些患者的中位随访时间为70个月。其中229例(35%)患者年龄超过60岁。对于60岁以下处于早期和中期阶段的患者,若遵循这些建议,治疗结果是良好的。在晚期阶段,伴有CS IIB大块病变和IVB期的患者预后较差。老年患者的预后仍然很差,尽管现在评估1989年所做修订的任何影响还为时过早。这些量身定制的原则通常在早期和中期阶段所需的分期和/或治疗比一般情况要少,应用于未经选择的HD患者群体时产生了良好的效果。在1994年的修订中,这些建议仅做了微小的改动。